← FDA DRUG APPROVALS

FDA ANDA · ANDA091623

THIAMINE HYDROCHLORIDE

Sponsor: MYLAN INSTITUTIONAL

APPLICATION
ANDA091623
TYPE
ANDA
ORIGINAL APPROVAL
2012-06-25
LATEST ACTION
2012-11-29
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

THIAMINE HYDROCHLORIDEPrescription
THIAMINE HYDROCHLORIDE 100MG/ML · INJECTABLE · INJECTION

Approval history

2012-11-29Labeling · Supplement 1 · standardAP
2012-06-25OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →